Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMAVERA study of AZD3470 in classical Hodgkin lymphoma and peripheral T-cell lymphoma
CTR20262277Phase 2Active
- Sponsor
- AstraZeneca
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD3470 in classical Hodgkin lymphoma (cHL), peripheral T-cell lymphoma (PTCL), sponsored by AstraZeneca. Started Feb 2024; status: active.
02
Drugs
AZD3470
03
Conditions
classical Hodgkin lymphoma (cHL)peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on CTR20262277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262277.